Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Common Equity: 2013-2025

Historic Common Equity for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $311.7 million.

  • Phibro Animal Health's Common Equity rose 20.56% to $311.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $311.7 million, marking a year-over-year increase of 20.56%. This contributed to the annual value of $285.7 million for FY2025, which is 11.32% up from last year.
  • Latest data reveals that Phibro Animal Health reported Common Equity of $311.7 million as of Q3 2025, which was up 9.10% from $285.7 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Common Equity peaked at $311.7 million during Q3 2025, and registered a low of $215.9 million during Q1 2021.
  • Over the past 3 years, Phibro Animal Health's median Common Equity value was $270.8 million (recorded in 2023), while the average stood at $272.2 million.
  • In the last 5 years, Phibro Animal Health's Common Equity grew by 26.74% in 2021 and then fell by 9.16% in 2024.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Common Equity stood at $239.3 million in 2021, then increased by 12.15% to $268.4 million in 2022, then grew by 0.91% to $270.8 million in 2023, then declined by 8.86% to $246.8 million in 2024, then rose by 20.56% to $311.7 million in 2025.
  • Its Common Equity was $311.7 million in Q3 2025, compared to $285.7 million in Q2 2025 and $266.0 million in Q1 2025.